Inventor · disambiguated record
Hsiou-Ting Kuo
Also filed as: KUO HSIOU-TING
4 granted patents·4 pending applications·5 citations·filing 2017–2023
63Inventor score
Top patents by PatentIndex Score
8 records- 0185US11504441B2Radiolabeled compounds targeting the prostate-specific membrane antigenPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2021·Granted Nov 22, 2022·1 cites·20 claims
- 0280US10882871B218/19F-labelled compounds which target the prostate specific membrane antigenBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2017·Granted Jan 5, 2021·3 cites·20 claims
- 0372US12427209B2Dual mode 18F-labelled theranostic compounds and uses thereofPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2019·Granted Sep 30, 2025·1 cites·5 claims
- 0469US2023348535A1Radiometal-binding compounds for diagnosis or treatment of prostate specific membrane antigen-expressing cancerPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 0559US2023114807A1Radiolabeled compounds targeting the prostate-specific membrane antigenPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2022·Application pending·0 cites
- 0659US2025242064A1Cxcr4-targeting compounds, and methods of making and using the samePROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 0751US2020339625A1Novel radiometal-binding compounds for diagnosis or treatment of prostate specific membrane antigen-expressing cancerPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2018·Application pending·0 cites
- 0847US12472272B2Radiolabelled compounds for diagnosis or treatment of prostate-specific membrane antigen- expressing cancerPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2020·Granted Nov 18, 2025·0 cites·40 claims
Join the waitlist — get patent alerts
Get an alert when Hsiou-Ting Kuo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →